National Cancer Center;Chugai Seiyaku Kabushiki Kaisha
发明人:
Shuichi MITSUNAGA,Atsushi OCHIAI,Masafumi IKEDA
申请号:
US14878163
公开号:
US20160022812A1
申请日:
2015.10.08
申请国别(地区):
US
年份:
2016
代理人:
摘要:
We achieved the present invention on the basis of the finding that an excellent therapeutic effect against pancreatic cancer can be obtained by administering an IL-6 inhibitor and an antimetabolite to pancreatic cancer patients. We also found that metastatic lesions from human pancreatic cancer can be reduced and ascites can be eliminated.